Tuesday, May 21, 2013 Last update: 2:08 PM
Company Tech News as it Breaks
Ventria Bioscience
News articles for Ventria Bioscience:
Tuesday, February 12, 2013
- Ventria Bioscience and University of Southern California Awarded Grant to Develop a Fusion Protein for the Treatment of DiabetesThe National Institutes of Health has awarded a Small Business Innovation Research (SBIR) grant to Ventria Bioscience and the University of Southern California (USC), with the ... read more
Thursday, December 13, 2012
- In Vivo Characterization of Optiferrin™ Recombinant Human Transferrin Demonstrates Functional Similarity to Serum-Derived Human TransferrinA study comparing the in vivo receptor-binding and iron transport characteristics of Ventria Bioscience’s Optiferrin™ recombinant human transferrin (rhTF) to native, serum-derived human ... read more
Monday, December 3, 2012
- Ventria Bioscience Acquires Meristem Therapeutics’ Recombinant Lactoferrin Intellectual PropertyVentria Bioscience announces the completion of an agreement under which Ventria Bioscience will wholly acquire portions of the intellectual property portfolio relating to Recombinant Lactoferrin developed by the ... read more